Imovax Polio

Poliovirus (Inactivated) Type 3 (Saukett Strain), Poliovirus (Inactivated) Type 2 (Mef-1 Strain), and Poliovirus (Inactivated) Type 1 (Mahoney Strain), the active ingredient in Imovax Polio, is an inactivated vaccine presented as a sterile suspension for intramuscular or subcutaneous use. It is used to prevent poliomyelitis in individuals at risk.

GNH USA supplies Imovax Polio as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imovax Polio is an inactivated poliovirus vaccine indicated for the prevention of poliomyelitis, a viral infection of the nervous system. - Poliomyelitis (polio): induces protective immunity that prevents infection and disease. - Travel to endemic regions: provides immunity before exposure to circulating poliovirus. - Outbreak response: used in mass vaccination campaigns to interrupt transmission.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Redness or swelling: localized erythema or edema. - Low‑grade fever: transient temperature rise within 24‑48 hours. - Headache: mild headache following immunisation. - Fatigue: temporary tiredness.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Guillain‑Barré syndrome: rare autoimmune neuropathy. - Seizures: infrequent neurologic events. - Encephalitis: very rare inflammation of the brain. - Severe hypotension: marked drop in blood pressure post‑injection.

Precautions should be observed when administering Imovax Polio. - Allergy assessment: avoid if known hypersensitivity to any vaccine component. - Immunocompromised patients: evaluate risk as response may be reduced. - Pregnancy: discuss benefits versus potential risks with a healthcare provider. - Concurrent vaccines: follow recommended schedules and separate if required. - Storage at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Vaccination may be influenced by other therapies. Major Interactions (Avoid): - Live viral vaccines: avoid simultaneous administration to prevent interference. - Immunoglobulin therapy: may diminish vaccine efficacy. - Blood products: can affect immune response. Moderate Interactions (Monitor Closely): - Antipyretics (acetaminophen, ibuprofen): may mask fever, monitor symptom relief. - Corticosteroids: may reduce immunogenicity, assess timing and dose.